Cancer Research UK logo.
SearchDonate
  • Search

A study of carfilzomib and daratumumab for myeloma (CANDOR)

Overview

Cancer types:

Blood cancers, Myeloma

Status:

Closed

Phase:

Phase 3

Details

This study is for people whose myeloma has come back or whose treatment has stopped working.

Recruitment start: 9 October 2017

Recruitment end: 13 February 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr James Cavet

Supported by

Amgen

Last reviewed: 06 Mar 2018

CRUK internal database number: 15098

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Find a Clinical Trial

Search our clinical trials database for all cancer trials and studies recruiting in the UK.

An icon of two speech bubbles, indicating a conversation.

Cancer Chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.